• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用高维方法鉴定类风湿性关节炎易感基因。

Identifying rheumatoid arthritis susceptibility genes using high-dimensional methods.

作者信息

Liang Xueying, Gao Ying, Lam Tram K, Li Qizhai, Falk Cathy, Yang Xiaohong R, Goldstein Alisa M, Goldin Lynn R

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, Bethesda, Maryland 20892, USA.

出版信息

BMC Proc. 2009 Dec 15;3 Suppl 7(Suppl 7):S79. doi: 10.1186/1753-6561-3-s7-s79.

DOI:10.1186/1753-6561-3-s7-s79
PMID:20018074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2795981/
Abstract

Although several genes (including a strong effect in the human leukocyte antigen (HLA) region) and some environmental factors have been implicated to cause susceptibility to rheumatoid arthritis (RA), the etiology of the disease is not completely understood. The ability to screen the entire genome for association to complex diseases has great potential for identifying gene effects. However, the efficiency of gene detection in this situation may be improved by methods specifically designed for high-dimensional data. The aim of this study was to compare how three different statistical approaches, multifactor dimensionality reduction (MDR), random forests (RF), and an omnibus approach, worked in identifying gene effects (including gene-gene interaction) associated with RA. We developed a test set of genes based on previous linkage and association findings and tested all three methods. In the presence of the HLA shared-epitope factor, other genes showed weaker effects. All three methods detected SNPs in PTPN22 and TRAF1-C5 as being important. But we did not detect any new genes in this study. We conclude that the three high-dimensional methods are useful as an initial screening for gene associations to identify promising genes for further modeling and additional replication studies.

摘要

尽管已有多个基因(包括人类白细胞抗原(HLA)区域的强效应基因)和一些环境因素被认为与类风湿关节炎(RA)的易感性有关,但该疾病的病因尚未完全明确。对整个基因组进行复杂疾病关联筛查的能力对于识别基因效应具有巨大潜力。然而,在这种情况下,通过专门为高维数据设计的方法可以提高基因检测的效率。本研究的目的是比较三种不同的统计方法——多因素降维法(MDR)、随机森林法(RF)和综合法——在识别与RA相关的基因效应(包括基因-基因相互作用)方面的效果。我们基于先前的连锁和关联研究结果开发了一组基因测试集,并对这三种方法进行了测试。在存在HLA共享表位因子的情况下,其他基因的效应较弱。所有三种方法都检测到蛋白酪氨酸磷酸酶非受体型22(PTPN22)和肿瘤坏死因子受体相关因子1-补体成分5(TRAF1-C5)中的单核苷酸多态性(SNP)很重要。但在本研究中我们未检测到任何新基因。我们得出结论,这三种高维方法作为基因关联的初步筛查方法,对于识别有前景的基因以进行进一步建模和额外的重复研究是有用的。

相似文献

1
Identifying rheumatoid arthritis susceptibility genes using high-dimensional methods.使用高维方法鉴定类风湿性关节炎易感基因。
BMC Proc. 2009 Dec 15;3 Suppl 7(Suppl 7):S79. doi: 10.1186/1753-6561-3-s7-s79.
2
Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort.在一个发病队列中评估类风湿关节炎易感基因 HLA-DRB1、PTPN22、OLIG3/TNFAIP3、STAT4 和 TRAF1/C5。
Arthritis Res Ther. 2010;12(2):R57. doi: 10.1186/ar2969. Epub 2010 Mar 30.
3
A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.一种候选基因方法将TRAF1/C5区域鉴定为类风湿性关节炎的一个风险因素。
PLoS Med. 2007 Sep;4(9):e278. doi: 10.1371/journal.pmed.0040278.
4
TRAF1 polymorphisms associated with rheumatoid arthritis susceptibility in Asians and in Caucasians.与亚洲人和高加索人类风湿关节炎易感性相关的TRAF1基因多态性。
Arthritis Rheum. 2009 Sep;60(9):2577-84. doi: 10.1002/art.24759.
5
Summarizing techniques that combine three non-parametric scores to detect disease-associated 2-way SNP-SNP interactions.总结了三种非参数评分方法相结合的技术,用于检测与疾病相关的双向 SNP-SNP 相互作用。
Gene. 2014 Jan 1;533(1):304-12. doi: 10.1016/j.gene.2013.09.041. Epub 2013 Sep 25.
6
Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis.类风湿关节炎易感性基因与类风湿关节炎患者的血脂水平相关。
Ann Rheum Dis. 2011 Jun;70(6):1025-32. doi: 10.1136/ard.2010.144634. Epub 2011 Mar 11.
7
Genetics of rheumatoid arthritis - a comprehensive review.类风湿关节炎的遗传学——全面综述。
Clin Rev Allergy Immunol. 2013 Oct;45(2):170-9. doi: 10.1007/s12016-012-8346-7.
8
The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status.蛋白酪氨酸磷酸酶非受体型22(PTPN22)基因R620W多态性与类风湿因子(RF)阳性类风湿关节炎呈剂量依赖性相关,但与人类白细胞抗原SE(HLA-SE)状态无关。
Genes Immun. 2005 Mar;6(2):129-33. doi: 10.1038/sj.gene.6364159.
9
Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.一项大型队列研究中人类白细胞抗原、PTPN22、CTLA4基因与类风湿关节炎自身抗体状态、诊断年龄及骨侵蚀等表型之间的关联。
Ann Rheum Dis. 2008 Mar;67(3):358-63. doi: 10.1136/ard.2007.071662. Epub 2007 Jul 31.
10
Allelic based gene-gene interactions in rheumatoid arthritis.类风湿关节炎中基于等位基因的基因-基因相互作用
BMC Proc. 2009 Dec 15;3 Suppl 7(Suppl 7):S76. doi: 10.1186/1753-6561-3-S7-S76.

引用本文的文献

1
Two-phase SSU and SKAT in genetic association studies.基因关联研究中的两阶段SSU和SKAT
J Genet. 2020;99.
2
TRAF1 Signaling in Human Health and Disease.TRAF1 在人类健康和疾病中的信号转导作用。
Front Immunol. 2018 Dec 18;9:2969. doi: 10.3389/fimmu.2018.02969. eCollection 2018.
3
Fitting Proportional Odds Model to Case-Control data with Incorporating Hardy-Weinberg Equilibrium.将比例优势模型应用于病例对照数据并纳入哈迪-温伯格平衡
Sci Rep. 2015 Nov 26;5:17286. doi: 10.1038/srep17286.
4
Causal graph-based analysis of genome-wide association data in rheumatoid arthritis.基于因果图的类风湿关节炎全基因组关联数据分析。
Biol Direct. 2011 May 18;6:25. doi: 10.1186/1745-6150-6-25.
5
The challenge of detecting epistasis (G x G interactions): Genetic Analysis Workshop 16.检测上位性(G x G 相互作用)的挑战:遗传分析研讨会 16。
Genet Epidemiol. 2009;33 Suppl 1(0 1):S58-67. doi: 10.1002/gepi.20474.

本文引用的文献

1
Exploring epistasis in candidate genes for rheumatoid arthritis.探索类风湿关节炎候选基因中的上位性。
BMC Proc. 2007;1 Suppl 1(Suppl 1):S70. doi: 10.1186/1753-6561-1-s1-s70. Epub 2007 Dec 18.
2
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.全基因组研究:TRAF1-C5作为类风湿关节炎的一个风险基因座
N Engl J Med. 2007 Sep 20;357(12):1199-209. doi: 10.1056/NEJMoa073491. Epub 2007 Sep 5.
3
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.对14000例七种常见疾病患者及3000例共享对照进行全基因组关联研究。
Nature. 2007 Jun 7;447(7145):661-78. doi: 10.1038/nature05911.
4
Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions.在存在基因-基因和基因-环境相互作用的情况下进行强大的多位点基因关联测试。
Am J Hum Genet. 2006 Dec;79(6):1002-16. doi: 10.1086/509704. Epub 2006 Oct 20.
5
High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33.对642个患有类风湿性关节炎的白种人家庭进行的高密度单核苷酸多态性分析,在11p12和2q33上确定了两个新的连锁区域。
Genes Immun. 2006 Jun;7(4):277-86. doi: 10.1038/sj.gene.6364295. Epub 2006 May 4.
6
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4.在来自北美和瑞典的4000多个样本中对类风湿关节炎假定候选基因关联进行复制研究:易感性与蛋白酪氨酸磷酸酶非受体型22(PTPN22)、细胞毒性T淋巴细胞相关抗原4(CTLA4)和肽基精氨酸脱亚氨酶4(PADI4)的关联。
Am J Hum Genet. 2005 Dec;77(6):1044-60. doi: 10.1086/498651. Epub 2005 Nov 1.
7
Efficiency and power in genetic association studies.基因关联研究中的效率与效能
Nat Genet. 2005 Nov;37(11):1217-23. doi: 10.1038/ng1669. Epub 2005 Oct 23.
8
Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.多因素降维法揭示散发性乳腺癌中雌激素代谢基因间的高阶相互作用。
Am J Hum Genet. 2001 Jul;69(1):138-47. doi: 10.1086/321276. Epub 2001 Jun 11.
9
A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases.对多位类风湿性关节炎患者家族进行的全基因组筛查表明,其与其他自身免疫性疾病存在基因重叠。
Am J Hum Genet. 2001 Apr;68(4):927-36. doi: 10.1086/319518. Epub 2001 Mar 9.
10
Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins.利用双胞胎数据确定类风湿性关节炎的数量遗传贡献。
Arthritis Rheum. 2000 Jan;43(1):30-7. doi: 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B.